Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Clinical trial NCT01665768 · COMPLETED

Trial details

NCT number

NCT01665768

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-09-01

Primary completion

2017-10-01

Enrollment

56

View on ClinicalTrials.gov